← Open Payments lookup

MEGAN CANADY: Open Payments

NPI 1588007157 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$716 in 37 payments from 15 companies in 2025. Trend: 2023 $456 · 2024 $477 · 2025 $716

Food & beverage: $716
CompanyPaymentsAmount
ABBVIE INC.9$137
Takeda Pharmaceuticals U.S.A., Inc.4$102
Janssen Biotech, Inc.4$89
Regeneron Healthcare Solutions, Inc.3$64
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$60
GENZYME CORPORATION2$49
Aimmune Therapeutics, Inc.2$42
PFIZER INC.2$41
Lilly USA, LLC2$37
QOL Medical, LLC1$22

Products named: DUPIXENT, ENTYVIO, TREMFYA, LINZESS, XIFAXAN, VELSIPITY, RINVOQ, OMVOH.

Industry payments across TX — which companies pay providers there.